Max Robotics — Global Service Robot Directory + US Certification

About

Farzana A. Faisal is a leading urological surgeon and researcher whose work is reshaping postoperative care through evidence-based opioid stewardship and thromboembolism prevention. Her landmark prospective cohort study, the ORIOLES Initiative (59 citations), systematically tracked postdischarge opioid practices after radical prostatectomy, revealing critical patterns of overprescribing and patient usage that informed safer prescribing protocols. Building on this, she led the PREVENTER randomized clinical trial (37 citations), which provided definitive evidence on pharmacologic prophylaxis for venous thromboembolism after radical prostatectomy—a major step in reducing preventable complications. Dr. Faisal also spearheaded the development of evidence-based recommendations for opioid prescribing after endourological and minimally invasive urological surgery (13 citations), translating pilot data into actionable, procedure-specific guidelines that promote opioid stewardship across surgical specialties. Her work directly addresses the dual crises of surgical pain management and opioid misuse, offering clinicians clear, data-driven frameworks to minimize harm while optimizing patient recovery. With her contributions cited in high-impact urology and surgery journals, Dr. Faisal is recognized as a key voice in perioperative quality improvement and patient safety.